Announcements Trials
Browse Landscape

Status

Completed 8Recruiting 5Unknown 2Terminated 2Not yet recruiting 2Enrolling by invitation 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Lymphoid 2Myeloid 1

Conditions

Neoplasms 33Breast Neoplasms 33Lung Neoplasms 17Colorectal Neoplasms 15Prostatic Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Hematologic Neoplasms 12Carcinoma, Hepatocellular 12Stomach Neoplasms 11Pancreatic Neoplasms 11Diabetes Mellitus 9Melanoma 7Disease 7Colonic Neoplasms 7Pulmonary Disease, Chronic Obstructive 6Cardiovascular Diseases 6Barrett Esophagus 6Urinary Bladder Neoplasms 5Rectal Neoplasms 5Liver Neoplasms 5Leukemia, Myeloid, Acute 5Fatigue 5Uterine Cervical Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pheochromocytoma 4Myasthenia Gravis 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma 4Lymphatic Metastasis 4

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Observational × Lymphoproliferative Disorders × Clear all
NCT04996706 2026-05-26

LEO

Mayo Clinic

Enrolling by invitation
21,000 enrolled
Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

OHSU Knight Cancer Institute

Enrolling by invitation
5,000 enrolled
LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡